Spine implant-maker raises $8M — 3 insights

Written by Eric Oliver | November 20, 2019 | Print  |

Complex spine disorder implant-maker Curiteva sold $8 million in equity to 16 investors Nov. 18, Mass Device reports.

What you should know:

1. Curiteva will use $2.2 million to pay off promissory notes and liquidation preferences. The company did not elaborate on what it would use the remaining funds for.

2. Curiteva developed the Sage cervical interbody fusion system and the Aptitude cervical plates.

3. The company is attempting to raise $20 million through the offering.

More articles on surface technology:
2 hospitals losing neurosurgery residency programs
Rothman, Carrum Health partner to expand healthcare benefits into tri-state area
Nexxt Spine to expand headquarters — 4 insights


© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers